p53 gene mutations in radiation-induced thyroid cancer

Area of Science:

• Molecular Oncology
• Radiation Carcinogenesis
• Genetics of Thyroid Cancer

Background:

• The role of specific oncogenes and tumor suppressor genes in radiation-induced thyroid cancer (RITC) is poorly understood.
• Mutations in the p53 tumor suppressor gene are typically associated with aggressive anaplastic thyroid cancer.
• Previous research has not extensively investigated p53 mutations in differentiated RITC.

Purpose of the Study:

• To investigate the presence and characteristics of p53 gene point mutations in papillary thyroid cancers developed after childhood radiation exposure.
• To compare p53 mutation status between RITC patients and a matched control group of non-exposed thyroid cancer patients.
• To explore the potential association between p53 mutations and clinicopathological features, including tumor spread, in RITC.

Main Methods:

• DNA was extracted from paraffin-embedded thyroid tumor specimens of 22 RITC patients and 18 matched controls.
• Exons 5-8 of the p53 gene were amplified using PCR.
• Mutations were screened using single-strand conformation polymorphism (SSCP) analysis and confirmed by cycle sequencing.

Main Results:

• Missense point mutations in the p53 gene were identified in 4 out of 22 RITC patients (18%).
• No missense mutations were detected in the control group of 18 thyroid cancer patients.
• Mutations in RITC patients were associated with male gender, lymph node involvement, and extrathyroidal invasion, but not distant metastasis or recurrence.

Conclusions:

• p53 gene point mutations may contribute to the pathogenesis of certain radiation-induced, well-differentiated thyroid cancers.
• These mutations appear to be linked to the local spread of radiation-induced papillary thyroid cancer.
• The findings highlight a potential role for p53 alterations in RITC beyond aggressive subtypes.